Invesco's passive stake increase is routine and immaterial. Monitor for any future conversion to a Schedule 13D, which would signal activist intent, but no such signal is present here.
LGND drugs
LGND drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $316.83entry
- T+1 · 5d ago −0.18%α +0.18% · $316.27
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Invesco Ltd. filed an amended Schedule 13G disclosing a 7.6% passive stake in Ligand Pharmaceuticals as of September 30, 2026, up from 1,497,232 shares in the prior filing to 1,520,911 shares. The increase is modest and consistent with passive portfolio rebalancing, with no indication of activist intent.
Key Financial Metrics
Key Facts
- Invesco Ltd. reported beneficial ownership of 1,520,911 shares of Ligand Pharmaceuticals common stock as of September 30, 2026
- The stake represents 7.6% of shares outstanding
- This is an amendment to a prior Schedule 13G filed August 13, 2026, which reported 1,497,232 shares
- The increase of approximately 23,679 shares is small and consistent with passive investment management
- Invesco certifies the shares were acquired and held in the ordinary course of business, not for changing or influencing control
Financial Impact
Invesco holds 1,520,911 shares valued at approximately $380M based on the $6.1B market cap and 7.6% stake
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000914208-26-000430 |
| Document: 0000914208-26-000430-index.html | 0000914208-26-000430 |
| Document: 0000914208-26-000430.txt | 0000914208-26-000430 |
Track record
29 reports on LGND
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Viewing Entry $316.83 Now $301.71 −4.77% settles Feb 9
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers